# Implantation of Continent Catheterizable Channel : Native Bladder or Enterocystoplasty ?

> **NCT04922437** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 106 (actual)

## Conditions studied

- Neurogenic Bladder
- Continent Cutaneous Urinary Diversion
- Mitrofanoff

## Interventions

- **PROCEDURE:** Native bladder implantation
- **PROCEDURE:** Enterocystoplasty implantation

## Key facts

- **NCT ID:** NCT04922437
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-06
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04922437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04922437, "Implantation of Continent Catheterizable Channel : Native Bladder or Enterocystoplasty ?". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04922437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*